兽医感染疾病诊断市场规模、份额和成长分析（按感染疾病类型、技术、动物类型、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，兽医感染疾病诊断市场规模将达到 21.8 亿美元，到 2025 年将达到 23.8 亿美元，到 2033 年将达到 47.3 亿美元，在预测期（2026-2033 年）内复合年增长率为 9%。

兽医感染疾病诊断市场对于快速有效地诊断动物疾病至关重要，从而透过加强预防、控制和治疗措施来改善动物健康。全球化和畜牧业实践的改变等因素导致感染疾病日益流行，推动了对可靠诊断解决方案的需求。然而，高成本、熟练专业人员短缺以及某些地区基础设施不足等挑战可能会阻碍市场准入和应用。儘管存在这些障碍，但快速检测和就地检验等技术进步正在创造许多机会。此外，人们对通用感染疾病的认识不断提高，以及「同一健康」理念的倡导，凸显了互联互通的卫生系统的重要性，这将推动兽医感染疾病诊断领域的增长，从而改善全球动物和公众健康。

兽医感染疾病诊断市场驱动因素

人们对动物健康和福利的日益关注是推动兽医感染疾病诊断市场发展的关键因素。随着宠物饲主和畜牧养殖户的知识水平不断提高，他们积极寻求先进的诊断工具和服务，以便及早发现并有效管理感染疾病。这种日益增强的意识凸显了监测动物健康的重要性，尤其是在近期全球健康挑战的背景下，这些挑战更加凸显了强大的诊断能力对于识别和应对通用感染疾病的重要性。因此，对可靠诊断方法的不断增长的需求持续显着地影响着市场格局。

兽医感染疾病诊断市场面临的限制因素

兽医感染疾病诊断市场面临的主要挑战之一是先进诊断技术和服务的高昂成本。对于小规模的兽医诊所，尤其是在资源匮乏地区，购买尖端诊断工具和设备所需的投资可能构成重大障碍。这种经济障碍可能会限制这些先进诊断方法的普及和广泛应用，最终阻碍整个市场的扩张。因此，成本因素在限制兽医专业人员实施创新解决方案的能力方面起着至关重要的作用，而这些创新解决方案有望改善动物感染疾病的诊断和治疗。

兽医感染疾病诊断市场趋势

就地检验（POC​​T）的普及是兽医感染疾病诊断市场的一大趋势，反映出兽医诊疗实践正朝着即时快速诊断的方向发展。这些高度便携且易于操作的POCT设备使兽医能够在现场进行检测，从而实现即时决策并改善患者预后。这一趋势不仅简化了诊断流程，还透过减少对中心实验室的依赖，提高了兽医诊疗的效率。因此，市场正在朝着优先考虑能够及时干预动物感染疾病管理的创新解决方案的方向发展，凸显了对便捷诊断技术的日益增长的需求。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球兽医感染疾病诊断市场规模（依感染疾病类型和复合年增长率划分）（2026-2033 年）

• 细菌感染疾病
• 病毒感染疾病
• 寄生虫感染疾病
• 其他感染疾病

全球兽医感染疾病诊断市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 免疫诊断方法
  • 横向流动化验
  • ELISA检测
• 其他免疫诊断技术
• 分子诊断
  • 聚合酵素链锁反应（PCR）检测
  • 微阵列
• 其他分子诊断测试
• 其他兽医诊断技术

全球兽医感染疾病诊断市场规模（按动物类型划分）及复合年增长率（2026-2033 年）

• 伴侣动物
  • 狗
  • 猫
  • 马
• 其他伴侣动物
• 食用动物
  • 牛
  • 猪
  • 家禽
  • 其他食用动物

全球兽医感染疾病诊断市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 标准与检验组织
• 兽医检查室和动物医院
• 照护现场/院内检测
• 研究机构和大学

全球兽医感染疾病诊断市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• IDEXX Laboratories, Inc.（US）
• Zoetis, Inc.（US）
• Thermo Fisher Scientific, Inc.（US）
• Virbac（France）
• bioMerieux SA（France）
• Heska Corporation（US）
• NEOGEN Corporation（US）
• QIAGEN NV（Netherlands）
• Randox Laboratories Ltd.（UK）
• Agrolabo S.pA.（Italy）
• Bio-Rad Laboratories（US）
• Bionote, Inc.（South Korea）
• Biogal Galed Labs（Israel）
• BioChek（Netherlands）
• Biopanda Reagents（UK）
• URIT Medical Electric Co. Ltd.（China）
• MEGACOR Diagnostik GmbH（Germany）
• Fassisi GmbH（Germany）
• Alvedia（France）
• SKYER, Inc.（South Korea）

结论与建议

Veterinary Infectious Disease Diagnostics Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.38 Billion in 2025 to USD 4.73 Billion by 2033, growing at a CAGR of 9% during the forecast period (2026-2033).

The veterinary infectious disease diagnostics market is essential for the timely and effective diagnosis of animal diseases, enhancing prevention, control, and treatment measures that lead to better health outcomes. The increasing prevalence of infectious diseases, driven by factors such as globalization and changing husbandry practices, heightens the demand for reliable diagnostic solutions. However, challenges such as high costs, lack of skilled professionals, and inadequate infrastructure in certain regions can hinder market access and implementation. Despite these obstacles, opportunities abound through technological advancements, including rapid and point-of-care tests. Additionally, the rising awareness of zoonotic diseases and the One Health approach underline the importance of interconnected health systems, promoting growth in the veterinary infectious disease diagnostics sector for improved animal and public health globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Veterinary Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Veterinary Infectious Disease Diagnostics Market Segments Analysis

Global Veterinary Infectious Disease Diagnostics Market is segmented by Infection Type, Technology, Animal Type, End User and region. Based on Infection Type, the market is segmented into Bacterial Infections, Viral Infections, Parasitic Infections and Other Infections. Based on Technology, the market is segmented into Immunodiagnostics, Other immunodiagnostic technologies, Molecular Diagnostics, Other molecular diagnostic tests and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals, Other companion animals and Food Producing Animals. Based on End User, the market is segmented into Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing and Research Institutes and Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Veterinary Infectious Disease Diagnostics Market

The rising consciousness regarding animal health and welfare is a crucial factor propelling the veterinary infectious disease diagnostics market. As pet owners and livestock producers become more informed, they are actively pursuing advanced diagnostic tools and services to facilitate the early detection and efficient management of infectious diseases. This heightened awareness underscores the importance of monitoring animal health, especially in light of recent global health events that have emphasized the necessity for strong diagnostic capabilities to identify and address potential zoonotic diseases. Consequently, this increasing demand for reliable diagnostics continues to shape the market landscape significantly.

Restraints in the Veterinary Infectious Disease Diagnostics Market

A notable challenge facing the veterinary infectious disease diagnostics market is the high expense linked to advanced diagnostic technologies and services. The investment required for implementing state-of-the-art diagnostic tools and equipment can be prohibitive, particularly for smaller veterinary practices or clinics in under-resourced areas. This financial barrier may restrict the availability and use of these sophisticated diagnostic methods, ultimately impeding overall market expansion. As a result, the cost factor plays a crucial role in limiting the ability of veterinary professionals to adopt innovative solutions that could enhance the diagnosis and treatment of infectious diseases in animals.

Market Trends of the Veterinary Infectious Disease Diagnostics Market

The Veterinary Infectious Disease Diagnostics market is witnessing a significant trend towards the adoption of point-of-care testing (POCT), reflecting a shift towards real-time, rapid diagnostic capabilities in veterinary settings. These portable and user-friendly POCT devices empower veterinarians to conduct on-site tests, leading to immediate decision-making and improved patient outcomes. This trend not only streamlines the diagnostic process but also enhances the efficiency of veterinary care by reducing reliance on centralized laboratory facilities. Consequently, the market is evolving to prioritize innovative solutions that facilitate timely interventions in infectious disease management for animals, underscoring a growing demand for accessible diagnostic technology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Veterinary Infectious Disease Diagnostics Market Size by Infection Type & CAGR (2026-2033)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Other Infections

Global Veterinary Infectious Disease Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunodiagnostics
  • Lateral flow assays
  • ELISA tests
• Other immunodiagnostic technologies
• Molecular Diagnostics
  • Polymerase chain reaction (PCR) tests
  • Microarrays
• Other molecular diagnostic tests
• Other Veterinary Diagnostic Technologies

Global Veterinary Infectious Disease Diagnostics Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Companion Animals
  • Dogs
  • Cats
  • Horses
• Other companion animals
• Food Producing Animals
  • Cattle
  • Swine
  • Poultry
  • Other food-producing animals

Global Veterinary Infectious Disease Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Reference Laboratories
• Veterinary Laboratories and Clinics
• Point of Care / In House Testing
• Research Institutes and Universities

Global Veterinary Infectious Disease Diagnostics Market Size & CAGR (2026-2033)

• North America (Infection Type, Technology, Animal Type, End User)
  • US
  • Canada
• Europe (Infection Type, Technology, Animal Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Infection Type, Technology, Animal Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Infection Type, Technology, Animal Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Infection Type, Technology, Animal Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IDEXX Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.pA. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogal Galed Labs (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioChek (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electric Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGACOR Diagnostik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fassisi GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvedia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SKYER, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations